Latest research

The scientific journal Nature has published a supplement focussing on multiple sclerosis research.

This study sheds light on what it takes to age relatively well when you have MS.

This research looked at the effect of a very low fat, plant-based diet to see if it affected peoples symptoms.

Further analysis of data from a clinical trial has shown that people taking Lemtrada were more likely to have an improvement in disability over the two years of the study, compared to people taking Rebif.

Siponimod reduced the risk of progression in secondary progressive MS (SPMS) according to results presented at the ECTRIMS meeting in London on 17 September.

Initial research results suggest siponimod may slow progression in people with secondary progressive MS

A large and very detailed survey has demonstrated that birth month can influence the risk of developing multiple sclerosis.

Amy Bowen from the MS Trust explains how it gets to the nub of the issues surrounding stem cell therapy for MS and why it's time for a roadmap for making the treatment safe and widely available on the NHS.

Amy Bowen, the MS Trust's Director of Service Development, reports from the CMSC conference on two talks about the importance of lifestyle issues and MS

Researchers in Canada have identified a gene that appears to significantly increase the risk of developing a rare rapidly progressing form of MS. 

Investigating the perspectives and experiences of people with MS and MS neurologists concerning the choice of DMD, starting and continuing treatment.

Study investigating if headaches were more common during an MS relapse and what type of headaches these were.